unknown
Stage
1
Investors
About
Exo Therapeutics is a small molecule drug discovery and development company using a proprietary platform to identify and develop inhibitors that target enzyme exosites for oncology and inflammatory diseases.
Explore Exo Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.